Dosimetry-based high-activity therapy with 131I-metaiodobenzylguanidine (131I-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma

被引：0
|
作者：
Jose Genolla
Trinidad Rodriguez
Pablo Minguez
Ricardo Lopez-Almaraz
Veronica Llorens
Aizpea Echebarria
机构：
[1] Cruces University Hospital,Department of Nuclear Medicine
[2] Cruces University Hospital,Department of Medical Physics and Radiation Protection
[3] Cruces University Hospital,Department of Pediatric Oncology and Hematology
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2019年 / 46卷
关键词：
High-risk neuroblastoma; I-mIBG therapy; Topotecan; Dosimetry;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1567 / 1575
页数：8
相关论文
共 50 条
  • [1] Dosimetry-based high-activity therapy with 131I-metaiodobenzylguanidine (131I-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma
    Genolla, Jose
    Rodriguez, Trinidad
    Minguez, Pablo
    Lopez-Almaraz, Ricardo
    Llorens, Veronica
    Echebarria, Aizpea
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (07) : 1567 - 1575
  • [2] Upfront Treatment of High-Risk Neuroblastoma With a Combination of 131I-MIBG and Topotecan
    Kraal, Kathelijne C. J. M.
    Tytgat, Godelieve A. M.
    van Eck-Smit, Berthe L. F.
    Kam, Boen
    Caron, Huib N.
    van Noesel, Max
    PEDIATRIC BLOOD & CANCER, 2015, 62 (11) : 1886 - 1891
  • [3] THE ROLE OF 131I-METAIODOBENZYLGUANIDINE (131I-MIBG) THERAPY IN UNRESECTABLE AND COMPROMISING LOCALIZED NEUROBLASTOMA
    Schoot, Reineke
    Bleeker, Gitta
    Heij, Hugo
    van Eck, Berthe
    Caron, Huib
    de Kraker, Jan
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 807 - 808
  • [4] Different outcomes for relapsed versus refractory neuroblastoma after therapy with 131I-metaiodobenzylguanidine (131I-MIBG)
    Zhou, Margaret J.
    Doral, Michelle Y.
    DuBois, Steven G.
    Villablanca, Judith G.
    Yanik, Gregory A.
    Matthay, Katherine K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (16) : 2465 - 2472
  • [5] Thyroid and Hepatic Function After High-Dose 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Neuroblastoma
    Quach, Alekist
    Ji, Lingyun
    Mishra, Vikash
    Sznewajs, Aimee
    Veatch, Janet
    Huberty, John
    Franc, Benjamin
    Sposto, Richard
    Groshen, Susan
    Wei, Denice
    Fitzgerald, Paul
    Maris, John M.
    Yanik, Gregory
    Hawkins, Randall A.
    Villablanca, Judith G.
    Matthay, Katherine K.
    PEDIATRIC BLOOD & CANCER, 2011, 56 (02) : 191 - 201
  • [6] Tumor Dosimetry And Radiobiological Study For High-Activity 131I-mIBG Therapy In The Management Of Refractory/Relapsed Neuroblastoma
    Polito, C.
    Cassano, B.
    Genovese, E.
    Longo, M.
    Donatiello, S.
    Insero, T.
    Valeri, S.
    Villani, M. F.
    Castellano, A.
    Garganese, M. C.
    Cannata, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S484 - S484
  • [7] Pinhole imaging of 131I-metaiodobenzylguanidine (131I-MIBG) in an animal model of neuroblastoma
    Roberto Accorsi
    Michael J. Morowitz
    Martin Charron
    John M. Maris
    Pediatric Radiology, 2003, 33 : 688 - 692
  • [8] Dosimetry-Based Tandem High-Dose 131I-MIBG Therapy For Paediatric Patients With High Risk Neuroblastoma
    Longo, M.
    Cassano, B.
    Genovese, E.
    Donatiello, S.
    Villani, M.
    Pizzoferro, M.
    Garganese, M.
    Serra, A.
    Castellano, A.
    Cannata, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S224 - S225
  • [9] The Role of 131I-MIBG in High-Risk Neuroblastoma Treatment
    Lessig, Megan Kinnear
    JOURNAL OF PEDIATRIC ONCOLOGY NURSING, 2009, 26 (04) : 208 - 216
  • [10] Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma
    DuBois, Steven G.
    Groshen, Susan
    Park, Julie R.
    Haas-Kogan, Daphne A.
    Yang, Xiaodong
    Geier, Ethan
    Chen, Eugene
    Giacomini, Kathy
    Weiss, Brian
    Cohn, Susan L.
    Granger, M. Meaghan
    Yanik, Gregory A.
    Hawkins, Randall
    Courtier, Jesse
    Jackson, Hollie
    Goodarzian, Fariba
    Shimada, Hiroyuki
    Czarnecki, Scarlett
    Tsao-Wei, Denice
    Villablanca, Judith G.
    Marachelian, Araz
    Matthay, Katherine K.
    CLINICAL CANCER RESEARCH, 2015, 21 (12) : 2715 - 2721
12345